Mode
Text Size
Log in / Sign up
N/A Completed N=100 Randomized Single-blind Health Services Research

Screening Wizard- Phase 2

Source: ClinicalTrials.gov NCT04646369 ↗
Enrolled (actual)
100
Serious AEs
0.0%
Results posted
Sep 2022
Primary outcomePrimary: Number of Participants Referred to Treatment — 0; 1; 0; 0 Participants

Summary

Screening Wizard (SW). Primary Care Providers (PCPs) are often uncertain about how to best refer adolescents who screen positive for depression or suicidality. Screen-positive youth who are either not in treatment, or express dissatisfaction with current treatment will be consented by an on-site research assistant (RA). Participants will answer questions via adaptive screens developed in a previous NIMH study (MH100155) for suicidal risk, anxiety, and mania. These will address perceived barriers and preferences about treatment. Participants are then randomized into 1 of 3 groups: 1) Providing the symptoms scores report of results to their provider based on their Screening Wizard responses (Screening as Usual); 2) Providing the symptoms scores report and their responses to treatment preferences and barriers including treatment recommendations their provider might suggest (Screening Wizard 2.0); or 3) Providing the report with treatment recommendations to their provider and a website called SOVA or Supporting Our Valued Adolescent, that is aimed at addressing perceptions about mental health providing support to teens through peer interaction that social workers and doctors moderate on a 24 hour a day basis (Screening Wizard 2.0 + SOVA).

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Referred to Treatment
0; 1; 0; 0; 0; 1
SECONDARY
Cost Analysis: Cost of Screening Wizard Intervention at Baseline
160.34
SECONDARY
Usability & Satisfaction
2.88; 2.89; 3.42; 3.39; 2.94; 2.71
SECONDARY
Satisfaction With Technical Components
6.41; 6.5; 6.13; 6.37; 5.81; 5.68

Eligibility Criteria

Inclusion Criteria

  • Youth aged 12-26yo
  • Biological or adoptive parent is willing to provide informed consent for teen to participate
  • Youth speaks and understands English

Exclusion Criteria

  • Non English speaking
  • No parent willing to provide informed consent
  • Is currently experiencing acute mania or psychosis, evidence of an intellectual or developmental disorder (IDD), life threatening medical condition that requires immediate treatment, or other cognitive or medical condition preventing youth from understanding study and/or participating.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04646369). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search